ArticleFrontiers in oncology2021

Targeting Mutated p53 Dependency in Triple-Negative Breast Cancer Cells Through CDK7 Inhibition.

Jingyu Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.